Evaluating Drug–Drug Interactions in Cancer Patients Receiving Anticoagulants and Antineoplastics
Despoina Pantazi, Teaching Staff at the Department of Chemistry, University of Ioannina, shared a post on LinkedIn:
“Take a look at my new article!
“Evaluating DDIs in cancer patients receiving anticoagulants and antineoplastics: a scoping review focusing on therapeutic efcacy and safety”
Medical Oncology (2025) 42:511
Many thanks to all participants in this work:
The oncologists:
Dr Melina Gerolatsite, Nanteznta Torounidou, Prof Davide Mauri, and Dr Nikos Tsoukalas
The hematologists:
Prof Grigoris Gerotziafas and Prof Elmina Lefkou
The cardiologist:
Costas Pappas, University Hospital of Ioannina
And
Emeritus professor Alexandros Tselepis for his comments.”
Title: Evaluating DDIs in cancer patients receiving anticoagulants and antineoplastics: a scoping review focusing on therapeutic efficacy and safety
Authors: Melina Yerolatsite, Nikolaos Tsoukalas, Grigoris Gerotziafas, Costas Pappas, Nanteznta Torounidou, Eleftheria Lefkou, Davide Mauri, Alexandros D. Tselepis, Despoina Pantazi
Read full article here.
Stay updated on the latest scientific advancements with Hemostasis Today.
-
Feb 16, 2026, 06:21C. Michael Gibson: Favorable Safety Outcomes With Asundexian
-
Feb 16, 2026, 06:18Jecko Thachil: What Do Clinicians Mean by “Coagulopathy”?
-
Feb 16, 2026, 06:04Inside 2026 Highlights of ASH in the Mediterranean, Middle East, and North Africa with Dr. Heghine Khachatryan
-
Feb 15, 2026, 10:56Don’t Miss PNH: Clinical Practice From ISTH – Medscape
-
Feb 15, 2026, 10:52Awareness and Research on Factor V Deficiency Are Critical – EHC
-
Feb 15, 2026, 10:43Peter Zdziarski: Protecting Patient Data in the Rare Disease Community
-
Feb 15, 2026, 10:31Michiel Voet: The Price Tag of a Whole Blood Strategy
-
Feb 15, 2026, 10:26Sifat Jubaira: K₂-EDTA vs K₃-EDTA – Same Anticoagulant, Very Different Accuracy
-
Feb 15, 2026, 09:29Gevorg Tamamyan: Childhood Cancer is Curable. Inequity Is Not